or
forgot password
  • cancer clinical trials in portland, OR

  • Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    Legacy Good Samaritan Hospital & Comprehensive Cancer Center
    Portland, Oregon 97210
    Breast Cancer, Cognitive/Functional Effects, Lung Cancer, Metastatic Cancer, Prostate Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Kaiser Permanente
    Portland, Oregon 97227
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    Legacy Emanuel Hospital and Health Center

    Trial Locations
    Legacy Emanuel Hospital and Health Center
    Legacy Emanuel Children's Hospital
    Oregon Health and Science University
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    CCOP - Columbia River Oncology Program

    Trial Locations
    CCOP - Columbia River Oncology Program
    Knight Cancer Institute at Oregon Health and Science University
    Legacy Emanuel Hospital and Health Center and Children's Hospital
    Kaiser Permanente Health Care - Portland
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Legacy Good Samaritan Hospital & Comprehensive Cancer Center
    Northwest Cancer Specialists at Rose Quarter Cancer Center
    Breast Cancer
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    Oregon Health and Science University
    Portland, Oregon 97201
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Study of ATN-224 in Patients With Prostate Cancer
    Oregon Health and Science University
    Portland, Oregon 97201
    Prostate Cancer
    Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)
    Oregon Health & Science University
    Portland, Oregon 97201
    Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic, Myelodysplastic Syndromes
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    Legacy Emanuel Hospital and Health Center

    Trial Locations
    Legacy Emanuel Hospital and Health Center
    Legacy Emanuel Children's Hospital
    Oregon Health and Science University
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia
    Oregon Health Sciences University
    Portland, Oregon
    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome, NK Cell Lymphoblastic Leukemia
    Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM)
    Oregon Health & Science University
    Portland, Oregon 97201
    Lymphangioleiomyomatosis
    Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer
    Providence Cancer Center at Providence Portland Medical Center

    Trial Locations
    Providence Cancer Center at Providence Portland Medical Center
    OHSU Knight Cancer Institute
    Kidney Cancer
    Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
    Adventist Medical Center
    Portland, Oregon 97216
    Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Legacy Emanuel Hospital and Health Center

    Trial Locations
    Legacy Emanuel Hospital and Health Center
    Adventist Medical Center
    Providence Portland Medical Center
    Oregon Health and Science University
    Kaiser Permanente
    Legacy Good Samaritan Hospital and Medical Center
    Northwest Cancer Specialists-Rose Quarter Cancer Center
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
    Legacy Emanuel Hospital and Health Center and Children's Hospital
    Portland, Oregon 97227
    Cognitive/Functional Effects, Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma
    Oregon Health and Science University Cancer Institute
    Portland, Oregon 97239-3098
    Multiple Myeloma and Plasma Cell Neoplasm
    Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
    Knight Cancer Institute at Oregon Health and Science University
    Portland, Oregon 97239-3098
    Bladder Cancer
    S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
    CCOP - Columbia River Oncology Program

    Trial Locations
    CCOP - Columbia River Oncology Program
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Adventist Medical Center
    Lung Cancer
    Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
    Providence Cancer Center at Providence Portland Medical Center

    Trial Locations
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Adventist Medical Center
    Lung Cancer
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    Legacy Emanuel Children's Hospital
    Portland, Oregon 97227
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    CCOP - Columbia River Oncology Program
    Portland, Oregon 97225
    Neurotoxicity, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Intermittent Chemotherapy With or Without GM-CSF for Metastatic HPRC
    Oregon Health and Science University Cancer Institute
    Portland, Oregon 97239-3098
    Prostate Cancer
    Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
    CCOP - Columbia River Oncology Program

    Trial Locations
    CCOP - Columbia River Oncology Program
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Lung Cancer
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    Legacy Emanuel Hospital and Health Center and Children's Hospital
    Portland, Oregon 97227
    Neuroblastoma
    Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors
    Oregon Health & Science University Dept. of OHSU (3)
    Portland, Oregon 97239
    Advanced Neuroendocrine Tumors
    A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer
    Oregon Health and Science University
    Portland, Oregon 97201
    Prostate Cancer, Hormone Refractory Prostate Cancer
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    CCOP - Columbia River Oncology Program

    Trial Locations
    CCOP - Columbia River Oncology Program
    Kaiser Permanente Health Care - Portland
    Leukemia